We are live on ! Find out more
FLACU

Frazier Lifesciences Acquisition Corporation Unit

Delisted

FLACU was delisted on the 22nd of November, 2022.

23 hedge funds and large institutions have $39.9M invested in Frazier Lifesciences Acquisition Corporation Unit in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less funds holding

Funds holding: 2623 (-3)

14% less capital invested

Capital invested by funds: $46.4M → $39.9M (-$6.5M)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FM
1
Frazier Management
Washington
$14.9M
RCM
2
RA Capital Management
Massachusetts
$9.92M
BI
3
BVF Inc
California
$4.95M
BCLSI
4
Bain Capital Life Sciences Investors
Massachusetts
$2.98M
MF
5
Magnetar Financial
Illinois
$1.99M
CCM
6
Context Capital Management
California
$1.2M
TAL
7
TIG Advisors LLC
New York
$887K
HF
8
HRT Financial
New York
$849K
WCMNY
9
Westchester Capital Management (New York)
New York
$836K -$92.1K -9,203 -10%
CIM
10
Cowen Investment Management
New York
$397K
MTCM
11
Mint Tower Capital Management
Netherlands
$194K
WC
12
Wealthspring Capital
New York
$164K
WMSA
13
Weiss Multi-Strategy Advisers
New York
$161K
Walleye Capital
14
Walleye Capital
New York
$141K +$6.99K +698 +5%
SIA
15
Schechter Investment Advisors
Michigan
$133K +$134K +13,400 New
GCIA
16
Gabelli & Co Investment Advisers
New York
$101K
AM
17
Anqa Management
New York
$58K
LIM
18
Longfellow Investment Management
Massachusetts
$41K -$300K -30,000 -88%
UBS Group
19
UBS Group
Switzerland
$11K +$5.1K +509 +88%
IC
20
Ikarian Capital
Texas
$9K -$723K -72,177 -99%
TRCT
21
Tower Research Capital (TRC)
New York
$5K
Morgan Stanley
22
Morgan Stanley
New York
$1K
Ensign Peak Advisors
23
Ensign Peak Advisors
Utah
-$4.44M -450,000 Closed
GCL
24
Glazer Capital LLC
New York
-$1.3M -132,331 Closed
BFM
25
Boothbay Fund Management
New York
-$107K -10,684 Closed

FLACU Hedge Fund Activity: Q4 2021 in Review

23 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q4 2021, worth a combined $39.9M — down 14% from $46.4M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of FLACU and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Walleye Capital, adding an estimated $6.99K. The largest seller was Ensign Peak Advisors, exiting entirely with an estimated $4.44M sold.

  • 23 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q4 2021, down from 26 in Q3 2021.
  • Funds reported $39.9M of Frazier Lifesciences Acquisition Corporation Unit stock for Q4 2021, down 14% quarter-over-quarter.
  • 1 fund opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q4 2021 and 4 closed out, a net change of -3 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q4 2021 was Walleye Capital, an estimated $6.99K added.
  • The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q4 2021 was Ensign Peak Advisors, an estimated $4.44M sold.

Based on aggregated 13F filings for Q4 2021.